Literature DB >> 25694423

Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d.

Biny K Joseph1, Hsing-Yin Liu1, Jamie Francisco1, Devanshi Pandya1, Melissa Donigan1, Christina Gallo-Ebert1, Caroline Giordano2, Adam Bata2, Joseph T Nickels3.   

Abstract

AMP kinase is a heterotrimeric serine/threonine protein kinase that regulates a number of metabolic processes, including lipid biosynthesis and metabolism. AMP kinase activity is regulated by phosphorylation, and the kinases involved have been uncovered. The particular phosphatases counteracting these kinases remain elusive. Here we discovered that the protein phosphatase 2A heterotrimer, PP2A(Ppp2r2d), regulates the phosphorylation state of AMP kinase by dephosphorylating Thr-172, a residue that activates kinase activity when phosphorylated. Co-immunoprecipitation and co-localization studies indicated that PP2A(Ppp2r2d) directly interacted with AMP kinase. PP2A(Ppp2r2d) dephosphorylated Thr-172 in rat aortic and human vascular smooth muscle cells. A positive correlation existed between decreased phosphorylation, decreased acetyl-CoA carboxylase Acc1 phosphorylation, and sterol response element-binding protein 1c-dependent gene expression. PP2A(Ppp2r2d) protein expression was up-regulated in the aortas of mice fed a high fat diet, and the increased expression correlated with increased blood lipid levels. Finally, we found that the aortas of mice fed a high fat diet had decreased AMP kinase Thr-172 phosphorylation, and contained an Ampk-PP2A(Ppp2r2d) complex. Thus, PP2A(Ppp2r2d) may antagonize the aortic AMP kinase activity necessary for maintaining normal aortic lipid metabolism. Inhibiting PP2A(Ppp2r2d) or activating AMP kinase represents a potential pharmacological treatment for many lipid-related diseases.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cholesterol; Diet; Kinase; Lipid; Phosphatase; Phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 25694423      PMCID: PMC4409226          DOI: 10.1074/jbc.M114.626259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Protein phosphatase 2A: the Trojan Horse of cellular signaling.

Authors:  E Sontag
Journal:  Cell Signal       Date:  2001-01       Impact factor: 4.315

2.  AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise.

Authors:  Hayley M O'Neill; Stine J Maarbjerg; Justin D Crane; Jacob Jeppesen; Sebastian B Jørgensen; Jonathan D Schertzer; Olga Shyroka; Bente Kiens; Bryce J van Denderen; Mark A Tarnopolsky; Bruce E Kemp; Erik A Richter; Gregory R Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

3.  STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.

Authors:  Hiroshi Tokumitsu; Hiroyuki Inuzuka; Yumi Ishikawa; Masahiko Ikeda; Ikutaro Saji; Ryoji Kobayashi
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

Review 4.  AMP-activated protein kinase: also regulated by ADP?

Authors:  D Grahame Hardie; David Carling; Steven J Gamblin
Journal:  Trends Biochem Sci       Date:  2011-07-23       Impact factor: 13.807

5.  Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes.

Authors:  K Højlund; M Poulsen; P Staehr; K Brusgaard; H Beck-Nielsen
Journal:  Eur J Clin Invest       Date:  2002-12       Impact factor: 4.686

6.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Authors:  Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

7.  A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells.

Authors:  Zeqin Lian; Yan Li; Jian Gao; Kai Qu; Jin Li; Linghua Hao; Song Wu; Haibo Zhu
Journal:  Lipids Health Dis       Date:  2011-04-29       Impact factor: 3.876

8.  Free fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolism.

Authors:  Thomas Galbo; Grith Skytte Olsen; Bjørn Quistorff; Erica Nishimura
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  Metformin pharmacogenomics: current status and future directions.

Authors:  Aaron C Pawlyk; Kathleen M Giacomini; Catherine McKeon; Alan R Shuldiner; Jose C Florez
Journal:  Diabetes       Date:  2014-08       Impact factor: 9.461

Review 10.  AMP-activated protein kinase: a target for drugs both ancient and modern.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Chem Biol       Date:  2012-10-26
View more
  27 in total

1.  Heat Shock Factor 1 Is a Direct Antagonist of AMP-Activated Protein Kinase.

Authors:  Kuo-Hui Su; Siyuan Dai; Zijian Tang; Meng Xu; Chengkai Dai
Journal:  Mol Cell       Date:  2019-09-24       Impact factor: 17.970

Review 2.  AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance.

Authors:  Daniel Garcia; Reuben J Shaw
Journal:  Mol Cell       Date:  2017-06-15       Impact factor: 17.970

Review 3.  PAR3-PAR6-atypical PKC polarity complex proteins in neuronal polarization.

Authors:  Sophie M Hapak; Carla V Rothlin; Sourav Ghosh
Journal:  Cell Mol Life Sci       Date:  2018-04-25       Impact factor: 9.261

4.  Digitoxin Suppresses Human Cytomegalovirus Replication via Na+, K+/ATPase α1 Subunit-Dependent AMP-Activated Protein Kinase and Autophagy Activation.

Authors:  Rupkatha Mukhopadhyay; Rajkumar Venkatadri; Jenny Katsnelson; Ravit Arav-Boger
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

5.  Spatial regulation of AMPK signaling revealed by a sensitive kinase activity reporter.

Authors:  Danielle L Schmitt; Stephanie D Curtis; Anne C Lyons; Jin-Fan Zhang; Mingyuan Chen; Catherine Y He; Sohum Mehta; Reuben J Shaw; Jin Zhang
Journal:  Nat Commun       Date:  2022-07-05       Impact factor: 17.694

6.  14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation.

Authors:  Anirban Kundu; Sandeep Shelar; Arindam P Ghosh; Mary Ballestas; Richard Kirkman; Hyeyoung Nam; Garrett J Brinkley; Suman Karki; James A Mobley; Sejong Bae; Sooryanarayana Varambally; Sunil Sudarshan
Journal:  J Biol Chem       Date:  2020-01-03       Impact factor: 5.157

7.  γ-6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A.

Authors:  Xue Gao; Liang Zhao; Shuangping Liu; Yuancheng Li; Siyuan Xia; Dong Chen; Mei Wang; Shaoxiong Wu; Qing Dai; Hieu Vu; Lauren Zacharias; Ralph DeBerardinis; Esther Lim; Christian Metallo; Titus J Boggon; Sagar Lonial; Ruiting Lin; Hui Mao; Yaozhu Pan; Changliang Shan; Jing Chen
Journal:  Mol Cell       Date:  2019-10-02       Impact factor: 17.970

8.  Distinct regulation of bioenergetics and translation by group I mGluR and NMDAR.

Authors:  Sudhriti Ghosh Dastidar; Shreya Das Sharma; Sumita Chakraborty; Sumantra Chattarji; Aditi Bhattacharya; Ravi S Muddashetty
Journal:  EMBO Rep       Date:  2020-04-29       Impact factor: 8.807

9.  Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells.

Authors:  Jun Luo; Yoshinobu Odaka; Zhu Huang; Bing Cheng; Wang Liu; Lin Li; Chaowei Shang; Chao Zhang; Yang Wu; Yan Luo; Shengyong Yang; Peter J Houghton; Xiaofeng Guo; Shile Huang
Journal:  Cells       Date:  2021-06-01       Impact factor: 7.666

10.  Activated Protein Phosphatase 2A Disrupts Nutrient Sensing Balance Between Mechanistic Target of Rapamycin Complex 1 and Adenosine Monophosphate-Activated Protein Kinase, Causing Sarcopenia in Alcohol-Associated Liver Disease.

Authors:  Gangarao Davuluri; Nicole Welch; Jinendiran Sekar; Mahesha Gangadhariah; Khaled Alsabbagh Alchirazi; Maradumane L Mohan; Avinash Kumar; Sashi Kant; Samjhana Thapaliya; McKenzie Stine; Megan R McMullen; Rebecca L McCullough; George R Stark; Laura E Nagy; Sathyamangla V Naga Prasad; Srinivasan Dasarathy
Journal:  Hepatology       Date:  2021-04-20       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.